Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
4Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
DBV Technologies S.A. (DBVT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
3Distinct source URLs
3High confidence
0.769Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
DBV Technologies S.A. Suppliers
Ticker
Name
Confidence
Evidence
DBVTF
DBV TECHNOLOGIES
72%
Reciprocal relationship from DBVTF graph: e initially classified as equity. Other conditions necessary for equity classification are met: • The Company has sufficient authorized and unissued shares a…
DBVTF
DBV TECHNOLOGIES
72%
o the the Service Agreement that the Company entered into with FLV on March 18, 2024 (the “PSM Services Agreement”), for the construction of a dedicated production line and facility and the transfer …
SNYNF
Sanofi
72%
the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We currently rely on a single contract manufacturer to manufacture and supply the acti…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from DBVT graph: the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We …
DBV Technologies S.A. Customers
Ticker
Name
Confidence
Evidence
DBVTF
DBV TECHNOLOGIES
72%
Reciprocal relationship from DBVTF graph: Reciprocal relationship from DBVT graph: Reciprocal relationship from DBVTF graph: Reciprocal relationship from DBVT graph: Reciprocal relationship from DBVT…
DBVTF
DBV TECHNOLOGIES
72%
e initially classified as equity. Other conditions necessary for equity classification are met: • The Company has sufficient authorized and unissued shares available to settle the contract after cons…
SNYNF
Sanofi
72%
the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We currently rely on a single contract manufacturer to manufacture and supply the acti…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from DBVT graph: the Viaskin patch both biological and chemical substances. Viaskin is a Highly Scalable Manufacturing Technology We …
DBV Technologies S.A. Debt Obligations
Instrument
Description
Confidence
Evidence
DBVT-DEBT-9032
Warrants outstanding: 3.11
90%
xbrl warrant detail from xbrl 2025-12-31.
DBVT-DEBT
Debt stack $1.5M
90%
Market cache reports total debt of $1.5M.
DBV Technologies S.A. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for DBV Technologies S.A..
DBV Technologies S.A. Ownership
Holder
Name
Confidence
Evidence
DBVT-OWNER-VIVO-CAPITAL-LLC
Vivo Capital, LLC
90%
13F overlay lists Vivo Capital, LLC as top holder; 72 tracked holders.
